Individual Patient Data Analysis of Viabahn for Peripheral Arterial Disease

NCT05459818 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 977

Last updated 2026-01-07

No results posted yet for this study

Summary

To evaluate the effectiveness of the VSX device in pre-determined patient populations to understand the patient characteristics that impact outcomes.

Conditions

  • Peripheral Vascular Diseases

Interventions

DEVICE

Viabahn implanted

An individual patient data analysis obtained from databases used in prospective studies that published results of patients treated with the latest generation heparin-bonded Viabahn in the femoropopliteal artery.

Sponsors & Collaborators

  • Rijnstate Hospital

    lead OTHER

Principal Investigators

  • MMPJ Reijnen, Prof · Rijnstate

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-12
Primary Completion
2025-10-01
Completion
2025-10-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05459818 on ClinicalTrials.gov